Technology and Evolution of GLP-1
Why Did GLP-1 Medicines Become a Global Trend?
Written by Dr. Ajay V. Kaduskar, Diabetologist, Nagpur
MD (Medicine), PGDHSc (Diabetology), FEACD (The Netherlands)
Published · 4 min read
Quick answer
GLP-1 medicines became a global trend because clinical trials showed large, reliable weight loss and health benefits in people with obesity and diabetes, because obesity affects hundreds of millions of people, because celebrities and social media amplified the results, and because new brands, doses and competition made the medicines more visible. A trend is not a reason to start a medicine. Suitability should be decided by a doctor.
A few years ago, few people outside diabetes clinics had heard of GLP-1. Today, the term appears in news, social media and family conversations. What changed so fast, and what should you take from it?
What changed in the science?
-
Earlier weight-loss medicines gave modest results and had safety concerns.
-
Higher-dose GLP-1 medicines showed average weight loss many times greater in trials.
-
Studies showed benefits for the heart, kidneys, liver and sleep apnoea in selected patients.
-
Tirzepatide raised expectations further.
-
Obesity began to be seen as a chronic disease, not a failure of willpower.
Why is obesity such a big problem?
Obesity raises the risk of type 2 diabetes, heart disease, fatty liver, joint problems and some cancers. In India, many people develop diabetes at lower body weights, and belly fat is common. Few effective long-term options existed before, so the arrival of strong medicines drew attention.
How did social media and celebrities play a part?
Dramatic before-and-after stories spread quickly online. Public figures spoke about using these medicines. This created strong demand and curiosity, but also myths, misuse and unrealistic expectations. Many posts do not show side effects, regain after stopping or the supervision behind the results.
What role did the market play?
-
Companies invested heavily in research and marketing.
-
Supply shortages in some countries drew headlines.
-
New brands and local manufacturing increased visibility, and in India prices began to fall.
-
Insurance, employers and governments started discussing coverage.
-
Investors tracked the sector as one of the biggest in medicine.
What is different in India?
India has a very large number of people with diabetes and obesity risk. Cost, access and cultural attitudes to weight shape the conversation. With more brands entering the market, interest is high. At the same time, concerns about unsupervised use, counterfeit products and online sales have grown.
What should you be careful about?
-
Trend-driven decisions without medical advice
-
Buying injectables from unverified websites or sellers
-
Expecting a quick, permanent fix
-
Ignoring diet, exercise and sleep
-
Using medicines for small cosmetic weight loss when risks may outweigh benefits
Who should seriously consider them?
People with type 2 diabetes, especially with obesity, heart or kidney disease, and people with obesity and weight-related health problems may benefit most. A doctor can assess your health and risks.
When should you see a doctor?
If you are considering a GLP-1 medicine, see a diabetologist for a proper assessment. Do not start on someone else's advice or from an online source.
What to remember
-
GLP-1 medicines grew popular because of strong trial results and a huge need.
-
Social media and celebrity stories fuelled demand.
-
More brands and falling prices have increased access in India.
-
Trend does not mean suitability. Medical advice is essential.
-
Lifestyle remains the foundation.
It is good that obesity and diabetes are finally being taken seriously. Use the buzz as a reason to speak with a doctor, not as a shortcut. To get honest, personalised advice, consult Dr. Ajay V. Kaduskar, a diabetologist at Niramay Clinics in Nagpur.
Sources and further reading
Frequently asked questions
Because they produce significant weight loss and improve blood sugar and other health markers. Social media, celebrity stories and growing awareness of obesity as a medical condition also boosted interest.
No. They were first used for type 2 diabetes and may also help the heart, kidneys and liver in selected patients. Weight management is one of several uses.
The science behind them is solid, and they are likely to remain important. But hype can lead to misuse. Decisions should rest on medical advice, not social media.
No. They are not suitable for people with certain thyroid cancers, pancreatitis, pregnancy plans and some other conditions. Your doctor will check your history before prescribing.
You should not buy them from unverified websites. Fake or unsafe products exist. Use a prescription and a licensed pharmacy.
Not necessarily. Many people lose weight through diet, activity and sleep. A medicine is considered if you have obesity or weight-related disease and need more help, after discussion with a doctor.
Related reading
- Full guide: GLP-1 drugs
- The Surprising History of GLP-1 Drugs
- Dual and Triple Agonists: What Comes After Semaglutide?
- Is a GLP-1 Medicine Worth the Cost? A Decision Guide
- Who Should Not Take GLP-1 Medicines?
- How GLP-1 Injection Pens Work: The Technology
- Oral GLP-1 Tablets: Are Pills Replacing Injections?
If you would like advice suited to your own reports and medicines, you can book an appointment or visit Niramay Clinics in Dhantoli, Nagpur.
Related services
More from the Health Library
Ready to talk to a specialist?
Call 0712 2422214 or +91 84591 41584, message us on WhatsApp, or use the appointment form. Please bring your previous reports and a list of the medicines you take.